• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Epidemiology . Investigating Symptom Duration Using Current Status Data: A Case Study of Postacute COVID-19 Syndrome

tetano

Editor, Senior Moderator
Epidemiology


. 2025 Jun 5.
doi: 10.1097/EDE.0000000000001882. Online ahead of print. Investigating Symptom Duration Using Current Status Data: A Case Study of Postacute COVID-19 Syndrome

Charles J Wolock[SUP] 1 [/SUP], Susan Jacob[SUP] 2 [/SUP], Julia C Bennett[SUP] 2 [/SUP], Anna Elias-Warren[SUP] 2 [/SUP], Jessica O'Hanlon[SUP] 2 [/SUP], Avi Kenny[SUP] 3 4 [/SUP], Nicholas P Jewell[SUP] 5 6 [/SUP], Andrea Rotnitzky[SUP] 7 [/SUP], Stephen R Cole[SUP] 8 [/SUP], Ana A Weil[SUP] 9 10 [/SUP], Helen Y Chu[SUP] 2 [/SUP], Marco Carone[SUP] 7 [/SUP]



Affiliations
Abstract

Background: For infectious diseases, characterizing symptom duration is of clinical and public health importance. Symptom duration may be assessed by surveying infected individuals and querying symptom status at the time of survey response. For example, in a severe acute respiratory syndrome coronavirus 2 testing program at the University of Washington, participants were surveyed at least 28 days after testing positive and asked to report current symptom status. This study design yielded current status data: outcome measurements for each respondent consisted only of the time of survey response and a binary indicator of whether symptoms had resolved by that time. Such study design benefits from limited risk of recall bias, but analyzing the resulting data necessitates tailored statistical tools.
Methods: We review methods for current status data and describe a novel application of modern nonparametric techniques to this setting. The proposed approach is valid under weaker assumptions compared with existing methods, allows the use of flexible machine learning tools, and handles potential survey nonresponse. Our method relies on the assumption that the survey response time is conditionally independent of symptom resolution time within strata of measured covariates, and we propose an approach to assess the sensitivity of results to deviations from conditional independence.
Results: From the university study, we estimate that 19% of participants experienced ongoing symptoms 30 days after testing positive, decreasing to 7% at 90 days. We found the estimates to be more sensitive to violations of the conditional independence assumption at 30 days compared with 90 days. Female sex, fatigue during acute infection, and higher viral load were associated with slower symptom resolution.
Conclusion: The proposed method and accompanying sensitivity analysis procedure provide tools for investigators faced with current status data.

Keywords: Interval censoring; Long COVID; Machine learning; Nonparametric; Survival analysis.

 
Back
Top Bottom